Bristol Myers Squibb launches AI-powered ‘Mosaic’ hub in Mumbai
India plays a critical role in Bristol Myers Squibb’s global strategy
India plays a critical role in Bristol Myers Squibb’s global strategy
The U.S. oncology market is projected to soar from $81 billion in 2025 to $212 billion by 2034
LNK01006 is designed to deliver potent, selective inhibition of TYK2-mediated cytokine signaling with central nervous system exposure
The new site marks the company’s first operation in the region
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
Expands bioprocessing footprint across Asia
It's an acquisition that aims at forming one of the US's largest oncology trial networks
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
Subscribe To Our Newsletter & Stay Updated